NCT06896981View on ClinicalTrials.gov

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Polycystic Ovary Syndrome (PCOS) WomenObesity
Interventions
DRUG

Metformin with Semaglutide

One arm: Metformin 500 mg bd, Other arm: Metformin 500 mg bd + Semaglutide 0.5 mg once weekly

Trial Locations (1)

1000

RECRUITING

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER